- Report
- July 2025
- 136 Pages
Global
From €4073EUR$4,650USD£3,535GBP
- Report
- April 2025
- 147 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- January 2026
- 180 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 181 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 189 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- February 2026
- 386 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- November 2025
- 140 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- June 2022
- 300 Pages
Global
From €3153EUR$3,600USD£2,737GBP
The Apheresis Platelet market is a subset of the Blood Banking industry. It involves the collection of platelets from a donor's blood, which are then used to treat patients with low platelet counts. Platelets are a key component of the clotting process, and are essential for preventing and treating bleeding disorders. Apheresis Platelet collection is a safe and efficient way to collect platelets from a donor, and is often used in cases where a patient needs a large number of platelets.
Apheresis Platelet collection is a highly regulated process, and requires specialized equipment and trained personnel. The equipment used in the process is typically expensive, and the cost of collection is often passed on to the patient.
Companies in the Apheresis Platelet market include Haemonetics Corporation, Fresenius Kabi, Terumo BCT, and Fenwal Inc. Show Less Read more